Reata Pharmaceuticals competitors and similar companiesClear all

Reata Pharmaceuticals's competitors and similar companies include Apellis Pharmaceuticals, Alnylam Pharmaceuticals, Ionis Pharmaceuticals and Kadmon.
Reata Pharmaceuticals
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops therapeutics for patients with serious or life-threatening diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals
Apellis Pharmaceuticals is a biopharmaceutical company focused on the development of therapeutic compounds.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
Ionis Pharmaceuticals
Ionis Pharmaceuticals
Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.
Kadmon
Kadmon
Kadmon Corporation is a biopharmaceutical company offering products and services for the treatment and management of hepatitis C.
Founding Date
Founding Date
2002
Founding Date
2009
Founding Date
2002
Founding Date
1989
Founding Date
2010
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Plano, US HQ
Irving, US
Plano, US
Locations
Waltham, US HQ
München, DE
Zug, CH
San Francisco, US
Watertown, US
Locations
Cambridge, US HQ
Paris, FR
Milan, IT
Tokyo, JP
Amsterdam, NL
Stockholm, SE
Zug, CH
see more
Locations
Carlsbad, US HQ
Locations
New York, US HQ
Cambridge, US
South Brunswick Township, US
Warrendale, US
Employees
Employees
22079% increase
Employees
47627% increase
Employees
1,32324% increase
Employees
7577% decrease
Employees
1151% decrease
Valuation ($)
Valuation ($)
1.4 b
Valuation ($)
4.9 b
Valuation ($)
27.7 b
Valuation ($)
5.6 b
Valuation ($)
N/A
Twitter followers
Twitter followers
1.3 k
Twitter followers
1.3 k
Twitter followers
16 k
Twitter followers
4.3 k
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
7
Number of tweets (last 30 days)
27
Number of tweets (last 30 days)
8
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
2.3
Average likes per tweet (last 30 days)
3.9
Average likes per tweet (last 30 days)
9.1
Average likes per tweet (last 30 days)
6.4
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
85.71%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
267230
Alexa Website Rank
184577
Alexa Website Rank
376993
Alexa Website Rank
333062
Alexa Website Rank
N/A
Employee Rating
Employee Rating
3.6
Employee Rating
3.8
Employee Rating
4.2
Employee Rating
3.6
Employee Rating
2.8

Financial

Revenue (est.)
Revenue (est.)
$11.5m (FY, 2021)
Revenue (est.)
$66.6m (FY, 2021)
Revenue (est.)
$844.3m (FY, 2021)
Revenue (est.)
$810.5m (FY, 2021)
Revenue (est.)
$8.3m (FY, 2020)
Cost of goods
Cost of goods
N/A
Cost of goods
$200k (FY, 2021)
Cost of goods
$115m (FY, 2021)
Cost of goods
$10.8m (FY, 2021)
Cost of goods
N/A
Net income
Net income
($297.4m) (FY, 2021)
Net income
($746.4m) (FY, 2021)
Net income
($852.8m) (FY, 2021)
Net income
($28.6m) (FY, 2021)
Net income
($108.9m) (FY, 2020)

Operating

Phase I Trials Products
Phase I Trials Products
2 (FY, 2016)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
6 (FY, 2020)
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
4 (FY, 2016)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
24 (FY, 2020)
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
1 (FY, 2016)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
6 (FY, 2020)
Phase III Trials Products
N/A

Funding

Total funding raised
Total funding raised
$ 468.9m
Total funding raised
$ 88m
Total funding raised
$ 1.5b
Total funding raised
N/A
Total funding raised
$ 21.3m
For sources of this data, please see the company profile

View company profiles

Apellis Pharmaceuticals
HQ
Waltham, US
Employees
476↑ 27% increase

Apellis Pharmaceuticals is a biopharmaceutical company focused on the development of therapeutic compounds.

View company
Alnylam Pharmaceuticals
HQ
Cambridge, US
Employees
1,323↑ 24% increase

Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.

View company
Ionis Pharmaceuticals
HQ
Carlsbad, US
Employees
757↓ 7% decrease

Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.

View company
Kadmon
HQ
New York, US

Kadmon Corporation is a biopharmaceutical company offering products and services for the treatment and management of hepatitis C.

View company